APA (7th ed.) Citation

R, N., AJ, S., A, M., J, T., J, S., F, M., . . . R, B. (2020). Fluorescently-labeled fremanezumab is distributed to sensory and autonomic ganglia and the dura but not to the brain of rats with uncompromised blood brain barrier. Cephalalgia : an international journal of headache, 40(3), 229. https://doi.org/10.1177/0333102419896760

Chicago Style (17th ed.) Citation

R, Noseda, Schain AJ, Melo-Carrillo A, Tien J, Stratton J, Mai F, Strassman AM, and Burstein R. "Fluorescently-labeled Fremanezumab Is Distributed to Sensory and Autonomic Ganglia and the Dura but Not to the Brain of Rats with Uncompromised Blood Brain Barrier." Cephalalgia : An International Journal of Headache 40, no. 3 (2020): 229. https://doi.org/10.1177/0333102419896760.

MLA (9th ed.) Citation

R, Noseda, et al. "Fluorescently-labeled Fremanezumab Is Distributed to Sensory and Autonomic Ganglia and the Dura but Not to the Brain of Rats with Uncompromised Blood Brain Barrier." Cephalalgia : An International Journal of Headache, vol. 40, no. 3, 2020, p. 229, https://doi.org/10.1177/0333102419896760.